-
Noncompliance Common in Teens Prescribed STI Treatment in ED
drugs
June 03, 2019
Noncompliance Common in Teens Prescribed STI Treatment in ED.
-
A New Way to Fight a Previously 'Inoperable' Pancreatic Cancer
drugs
May 31, 2019
A New Way to Fight a Previously 'Inoperable' Pancreatic Cancer.
-
FDA Approves Jakafi (ruxolitinib) for the Treatment of Patients with Acute Graft-Versus-Host Disease
drugs
May 29, 2019
Incyte Corporation today announced that the U.S. Food and Drug Administration (FDA) has approved Jakafi (ruxolitinib) for the treatment of steroid-refractory acute GVHD in adult and pediatric patients 12 years and older.
-
Racial Disparity Seen in Prescriptions for Buprenorphine
drugs
May 21, 2019
Racial Disparity Seen in Prescriptions for Buprenorphine.
-
Recs Updated for TB Screening, Treatment in Health Care Workers
drugs
May 17, 2019
Recs Updated for TB Screening, Treatment in Health Care Workers.
-
NHS improvements to give patients faster access to pioneering treatments
pharmatimes
May 09, 2019
NHS improvements to give patients faster access to pioneering treatments.
-
New Treatment Guideline Focuses on Tourette Syndrome
drugs
May 09, 2019
New Treatment Guideline Focuses on Tourette Syndrome.
-
EU approval for Sanofi’s type 2 diabetes treatment
europeanpharmaceuticalreview
May 08, 2019
Suliqua is an innovative new combination therapy that has the potential to address significant unmet needs for people living with type 2 diabetes in Europe
-
World Asthma Day: can fevipiprant revolutionise asthma treatment?
pharmaceutical-technology
May 07, 2019
World Asthma Day aims to raise awareness of the burden of asthma. Increasingly, the standard of care for asthma, reliever and preventer inhalers, are being discovered to be insufficient in a number of ways.
-
Anti-malaria drug shows promise as Zika virus treatment
europeanpharmaceuticalreview
May 05, 2019
Chloroquine found to reduced the amount of Zika virus in maternal blood and neural progenitor cells in the foetal brain.